Literature DB >> 31130545

Determinants of Abnormal Cervical Cancer Screening Follow-Up And Invasive Cervical Cancer Among Uninsured and Underinsured Women in New Jersey.

Jennifer Tsui, Adana A Llanos, Michelle Doose, David Rotter, Antoinette Stroup.   

Abstract

OBJECTIVES: To identify determinants of follow-up care and diagnosis of invasive cervical cancer among uninsured/underinsured women screened for cervical cancer.
METHODS: We examined the associations between health care facility, area-level, and individual-level factors on the outcomes of interest in retrospective cohort of women from the New Jersey Cancer Education and Early Detection Program (2000-2015).
RESULTS: Women screened at department of health clinics (aOR:3.11, 95% CI: 2.30-4.20) and health care system-affiliated clinics (aOR:1.71, 95% CI: 1.11-2.64) had higher odds of lacking follow-up care compared with women in private physician practices. Similarly, women residing in areas with the highest unemployment had higher odds of lacking follow-up (aOR:1.48, 95% CI: 1.07-2.06). Delays in follow-up care were higher for women born in Central/South American countries compared with U.S.-born women (aOR: 1.46, 95% CI: 1.12-1.92).
CONCLUSIONS: Improved outreach efforts and multilevel strategies are needed to address the persistent barriers to appropriate follow-up care for underserved women.

Entities:  

Year:  2019        PMID: 31130545      PMCID: PMC6612267          DOI: 10.1353/hpu.2019.0050

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  24 in total

Review 1.  Process of care failures in invasive cervical cancer: systematic review and meta-analysis.

Authors:  Andrea R Spence; Patricia Goggin; Eduardo L Franco
Journal:  Prev Med       Date:  2007-06-22       Impact factor: 4.018

2.  Introduction: Understanding and influencing multilevel factors across the cancer care continuum.

Authors:  Stephen H Taplin; Rebecca Anhang Price; Heather M Edwards; Mary K Foster; Erica S Breslau; Veronica Chollette; Irene Prabhu Das; Steven B Clauser; Mary L Fennell; Jane Zapka
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

Review 3.  Bethesda 2014: improving on a paradigm shift.

Authors:  D C Wilbur; R Nayar
Journal:  Cytopathology       Date:  2015-12       Impact factor: 2.073

4.  Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).

Authors:  V B Benard; N C Lee; M Piper; L Richardson
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

5.  Recommendations for a national agenda to substantially reduce cervical cancer.

Authors:  Jennifer S Smith; Noel T Brewer; Debbie Saslow; Kenneth Alexander; Mildred R Chernofsky; Richard Crosby; Libby Derting; Leah Devlin; Charles J Dunton; Jeffrey Engle; Maria Fernandez; Mona Fouad; Warner Huh; Walter Kinney; Jennifer Pierce; Elena Rios; Mitchel C Rothholz; Judith C Shlay; Rivienne Shedd-Steele; Sally W Vernon; Joan Walker; Theresa Wynn; Gregory D Zimet; Baretta R Casey
Journal:  Cancer Causes Control       Date:  2013-07-05       Impact factor: 2.506

Review 6.  The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Authors:  Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

7.  Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.

Authors:  Ambili Ramachandran; Frederick R Snyder; Mira L Katz; Julie S Darnell; Donald J Dudley; Steven R Patierno; Mechelle R Sanders; Patricia A Valverde; Melissa A Simon; Victoria Warren-Mears; Tracy A Battaglia
Journal:  Cancer       Date:  2015-08-19       Impact factor: 6.860

8.  Correlates of cervical cancer screening among underserved Hispanic and African-American women.

Authors:  Mohsen Bazargan; Shahrzad H Bazargan; Muhammad Farooq; Richard S Baker
Journal:  Prev Med       Date:  2004-09       Impact factor: 4.018

9.  Neighborhood factors associated with time to resolution following an abnormal breast or cervical cancer screening test.

Authors:  Jesse J Plascak; Adana A Llanos; Michael L Pennell; Rory C Weier; Electra D Paskett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-09-09       Impact factor: 4.254

10.  Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003-2014.

Authors:  Meg Watson; Vicki Benard; Elaine W Flagg
Journal:  Prev Med Rep       Date:  2018-02-02
View more
  3 in total

1.  Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.

Authors:  Alexandra Bukowski; Cathrine Hoyo; Michael G Hudgens; Wendy R Brewster; Fidel Valea; Rex C Bentley; Adriana C Vidal; Rachel L Maguire; John W Schmitt; Susan K Murphy; Kari E North; Jennifer S Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-08-02       Impact factor: 4.090

2.  Adherence to triage among women with HPV-positive self-collection: a study in a middle-low income population in Argentina.

Authors:  Melisa Paolino; Juan Gago; Anabella Le Pera; Oscar Cinto; Laura Thouyaret; Silvina Arrossi
Journal:  Ecancermedicalscience       Date:  2020-11-10

3.  Increased disparities associated with black women and abnormal cervical cancer screening follow-up.

Authors:  Teresa K L Boitano; Peter Ketch; Julia G Maier; Christine T Nguyen; Warner K Huh; J Michael Straughn; Isabel C Scarinci
Journal:  Gynecol Oncol Rep       Date:  2022-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.